BIM
FPRX

BlackRock Investment Management’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

BlackRock Investment Management’s Portfolio FPRX Stock Details FPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$5.45M Sell
108,726
-733
-0.7% -$38.5K 0.01% 1535
2016
Q3 		$5.75M Buy
109,459
+750
+0.7% +$35.8K 0.01% 1383
2016
Q2 		$4.5M Buy
108,709
+26,266
+32% +$1.14M 0.01% 1509
2016
Q1 		$3.35M Buy
82,443
+4,721
+6% +$162K ﹤0.01% 1644
2015
Q4 		$3.23M Buy
77,722
+1,879
+2% +$63K ﹤0.01% 1720
2015
Q3 		$1.17M Sell
75,843
-283
-0.4% -$6.08K ﹤0.01% 2492
2015
Q2 		$1.89M Buy
76,126
+17,024
+29% +$379K ﹤0.01% 2284
2015
Q1 		$1.35M Buy
59,102
+9,323
+19% +$235K ﹤0.01% 2313
2014
Q4 		$1.34M Sell
49,779
-319
-0.6% -$5.49K ﹤0.01% 2343
2014
Q3 		$588K Buy
50,098
+924
+2% +$11.7K ﹤0.01% 2884
2014
Q2 		$765K Buy
49,174
+29,770
+153% +$427K ﹤0.01% 2799
2014
Q1 		$381K Buy
19,404
+6,618
+52% +$112K ﹤0.01% 3079
2013
Q4 		$215K Buy
+12,786
New +$159K ﹤0.01% 3209

Other funds holding FPRX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BlackRock Investment Management's FPRX Position: Q4 2016 in Review

BlackRock Investment Management reduced its Five Prime Therapeutics, Inc. (FPRX) stake by 0.67% in Q4 2016, selling an estimated $38.5K and leaving 108,726 shares worth $5.45M. The position accounts for 0.01% of the portfolio, ranked #1535.

BlackRock Investment Management first reported a position in FPRX in Q4 2013 and has held it in 13 quarters since. The position peaked at $5.75M in Q3 2016. 172 funds tracked by Wall St. Rank hold FPRX as of Q4 2016.

  • BlackRock Investment Management held 108,726 shares of Five Prime Therapeutics, Inc. worth $5.45M as of Q4 2016.
  • BlackRock Investment Management sold 733 Five Prime Therapeutics, Inc. shares in Q4 2016, an estimated $38.5K.
  • Five Prime Therapeutics, Inc. made up 0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #1535 holding.
  • BlackRock Investment Management first reported a position in Five Prime Therapeutics, Inc. in Q4 2013 and has held it in 13 quarters since.
  • BlackRock Investment Management's Five Prime Therapeutics, Inc. position peaked at $5.75M in Q3 2016.
  • 172 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.